PIK3CD and neoplasm: In order to assess the significance of these results in a tractable cellular model relevant to HSCT, we measured the effects of pharmacological p110δ inactivation in T cell responses to tumor-primed allogeneic bone marrow-derived dendritic cells (BMDCs).